Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support... see more

PINL:GRPOF - Post Discussion

Traxion Sab De Cv Ord Shs > I laugh at the new release
View:
Post by Stockthoughts on Jul 27, 2020 8:52am

I laugh at the new release

So awaye and terpacan do not have billion market potential  anymore? Why did TBP spent so much money to get the DIN then say "we spin it off so we can focus on other billion market potential. 


not only that , TBP still provide funding of $500,000 for ads? Wait, we gave it away but we still fund it? Oh wait, they new company didn't have the money it was owe by Guy and his buddies just to move assets around. 2 years from now, Guy probably intent to buy it back at 20 times the price

TBP just sold the only subsidy that have products to sell and generate revenue. it is okay to shareholders?

Comment by youngpupper on Jul 27, 2020 9:43am
I don't think you understand pre revenue biotechs, the business model is simple: sell any possible revenue generating assets and continue to spend/raise to dilute shareholders ! Easy money! 
Comment by Stockthoughts on Jul 27, 2020 1:52pm
I don't think you understand that Guy just sold the only company that can generate revenue and selling it for 1m-1.5 million in shares does nothing to shareholders. It is a way for Guy and his buddies to take it all for themselves at shareholders expense. They will continue making shareholder suffer (many times)  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities